Analysis of Colinz Laboratories Limited (COLINZ)
Colinz Laboratories Limited has been showing some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the 50 mark, indicating a balanced market sentiment between buying and selling pressure.
The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a lack of strong trend in the stock price. The MACD histogram has been negative in some instances, indicating potential bearish momentum.
The Moving Average (MA) indicator has been relatively stable, with the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) showing similar values.
Overall, based on the recent data, it seems that Colinz Laboratories Limited is experiencing some price consolidation and uncertainty in market direction. Traders and investors may need to closely monitor the stock for any potential breakout or trend reversal.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the net income has also shown a positive trend, rising from $57.4 billion in 2020 to $97 billion in 2023.
3. The company's EBITDA has also been increasing over the years, indicating improved operational efficiency.
4. The basic and diluted earnings per share (EPS) have remained relatively stable over the years, with slight fluctuations.
5. The company has been able to maintain a healthy gross profit margin, despite fluctuations in the cost of goods sold.
6. Operating income and EBIT have shown an increasing trend, reflecting the company's ability to effectively manage its operating expenses.
7. The company has been able to generate consistent income from its core operations, as seen in the net income from continuous operations.
8. Overall, the financial performance of the company seems to be on a positive trajectory, with increasing sales and profitability over the years.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:
1. The total assets have been increasing over the years, indicating growth in the company's overall value.
2. Current assets have fluctuated, with some years showing higher cash reserves and others showing higher inventory levels.
3. Non-current assets have generally increased, with investments and advances being a significant portion of the assets.
4. Total liabilities have also been on the rise, but at a slower pace compared to total assets.
5. Shareholders' equity has shown variations, influenced by factors such as common stock, retained earnings, and other equity components.
6. The company has been managing its short-term and long-term debts, with fluctuations in the amounts over the years.
7. The provision for risks and charges has also varied, indicating changes in the company's risk management strategies.
8. Overall, the company seems to be in a stable financial position, with a focus on managing its assets, liabilities, and equity effectively.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%
- Fiscal year ends: September 30, 2023
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%
- Most recent quarter: March 31, 2024
- Return on assets TTM: 22.073999%
- Return on equity TTM: 147.25%
Stock statistics:
- Short ratio: 1.66
- Float shares: 15,308,320,742
- Shares short: 94,308,265
- Average 10-day volume: 52,903,608
- Average 90-day volume: 62,823,269
- Shares outstanding: 15,334,099,968
- Percent held by insiders: 5.22%
- Percent held by institutions: 57.555%
- Short percent of shares outstanding: 0.62%
Valuation metrics:
- PEG ratio: 26.213001
- Forward PE: 26.213001
- Trailing PE: 29.428572
- Enterprise value: $2,948,462,018,560
- Price to book MRQ: 39.181313
- Price to sales TTM: 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to revenue: 7.726
- Market capitalization: $2,906,118,684,672
Stock price summary:
- Beta: 1.264
- 50-day moving average: $173.6936
- 200-day moving average: $180.7906
- Fifty-two week low: $164.08
- Fifty-two week high: $199.62
- Fifty-two week change: 8.253%
Dividends and splits:
- Payout ratio: 14.93%
- Dividend date: May 16, 2024
- Last split date: August 31, 2020
- Ex-dividend date: May 10, 2024
- Last split factor: 4-for-1 split
- Forward annual dividend rate: $1
- 5-year average dividend yield: 0.73%
- Forward annual dividend yield: 0.5266761603816345%
- Trailing annual dividend rate: $0.97
- Trailing annual dividend yield: 0.5108758755701854%
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include acquisitions, capital expenditures, and the sale/purchase of investments.
7. The company has been utilizing stock-based compensation as part of its operations.
8. Overall, the company's financial performance seems to be stable, with some fluctuations in key metrics over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. For the current quarter ending on June 30, 2024:
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Number of Analysts: 26
- Year Ago EPS: $1.26
2. For the next quarter ending on September 30, 2024:
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Number of Analysts: 25
- Year Ago EPS: $1.46
3. For the current year ending on September 30, 2024:
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Number of Analysts: 39
- Year Ago EPS: $6.13
4. For the next year ending on September 30, 2025:
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Number of Analysts: 39
- Year Ago EPS: $6.59
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two fiscal years. It indicates growth in earnings compared to the previous year.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:
- The company is expected to have a growth rate of 7.5% in the current year and 9.7% in the next year.
- For the current quarter, the growth rate is estimated to be 5.6%, while for the next quarter it is projected to be 4.8%.
- Over the next 5 years, the company is expected to have a compound annual growth rate (CAGR) of 11%.
- However, when looking at the past 5 years, the company had a higher CAGR of approximately 20.1%.
Overall, it seems that the company is expected to experience a moderate growth rate in the near future compared to its performance in the past 5 years.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57 USD.MACD of COLINZ